Concordia Healthcare Corp. (NASDAQ:CXRX) Broker Price Targets For The Coming Week
by BRENTON AKERMAN | APRIL 10, 2016
Recently some investment brokers have made changes to their outstanding price targets on shares of Concordia Healthcare Corp. (NASDAQ:CXRX). According to data from Reuters, 2 analysts have a rating of “buy”, 8 analysts “outperform”, 2 analysts “hold”, 1 analysts “underperform” and 0 analysts “sell”.
Latest Analyst Ratings:
03/29/2016 – Concordia Healthcare Corp. had its “sector performer” rating reiterated by analysts at CIBC. They now have a USD 34 price target on the stock.
03/28/2016 – Concordia Healthcare Corp. had its “buy” rating reiterated by analysts at TD Securities. They now have a USD 45 price target on the stock.
03/28/2016 – Concordia Healthcare Corp. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 64 price target on the stock.
03/28/2016 – Concordia Healthcare Corp. had its “buy” rating reiterated by analysts at Laurentian Bank. They now have a USD 55 price target on the stock.
12/16/2015 – Concordia Healthcare Corp. had its “buy” rating reiterated by analysts at Canaccord Genuity.
12/03/2015 – Concordia Healthcare Corp. had its “hold” rating reiterated by analysts at Mackie.
10/16/2015 – Concordia Healthcare Corp. had its “sector outperform” rating reiterated by analysts at Scotiabank.
10/16/2015 – Concordia Healthcare Corp. had its “buy” rating reiterated by analysts at S&P Capital IQ. They now have a USD 60 price target on the stock.
The share price of Concordia Healthcare Corp. (NASDAQ:CXRX) was down -1.55% during the last trading session, with a day high of 27.70. 177967 shares were traded on Concordia Healthcare Corp.’s last session.
The stock’s 50 day moving average is 28.95 and its 200 day moving average is 33.44. The stock’s market capitalization is 1.35B. Concordia Healthcare Corp. has a 52-week low of 19.02 and a 52-week high of 89.10.